Data from previous studies in glioma, endometrial cancer, and other tumors suggested that the exogenous wild-type PTEN gene can profoundly inhibit the growth of tumor cells, promote cellular apoptosis, and cause cell cycle arrest at the G1 phase [22–27]. This evidence concerns the gene PTEN and neoplasm.